Treatment outcomes and cognitive function following electroconvulsive therapy in patients with severe depression

Table 3 Adverse events reported by the participants, n (%)

Adverse event	ECT group (n = 102)	Non-ECT group (n = 102)	P value
Headache	32 (31)	28 (27)	0.54
Nausea	24 (24)	22 (22)	0.76
Dizziness	18 (18)	16 (16)	0.72
Memory impairment	14 (14)	12 (12)	0.69
Insomnia	10 (10)	14 (14)	0.39
Weight gain	8 (8)	10 (10)	0.63
Sexual dysfunction	6 (6)	8 (8)	0.57
Agitation	4 (4)	6 (6)	0.51
Confusion	2 (2)	2 (2)	> 0.99
Seizure prolongation1	2 (2)	N/A2	N/A2

Data are presented as number and percentage.

¹Seizure prolongation was defined as a seizure duration > two min.

²Seizure prolongation was not applicable for the non-electroconvulsive therapy group. ECT: Electroconvulsive therapy; N/A: Not applicable.